PHS
GILD icon

Pekin Hardy Strauss’s Gilead Sciences GILD Stock Holding History

Pekin Hardy Strauss’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,000
Closed -$72K – 190
2017
Q4 		$72K Hold
1,000
– – 0.01% 183
2017
Q3 		$82K Hold
1,000
– – 0.02% 186
2017
Q2 		$70K Hold
1,000
– – 0.01% 183
2017
Q1 		$68K Buy
+1,000
New +$70.3K 0.01% 175

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Pekin Hardy Strauss's GILD Position: Q2 2026 in Review

Pekin Hardy Strauss held its Gilead Sciences (GILD) position steady in Q2 2026 at 3,908 shares worth $494K. The position accounts for 0.04% of the portfolio, ranked #317.

Pekin Hardy Strauss first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.48M in Q1 2020. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Pekin Hardy Strauss held 3,908 shares of Gilead Sciences worth $494K as of Q2 2026.
  • Pekin Hardy Strauss left its Gilead Sciences share count unchanged in Q2 2026.
  • Gilead Sciences made up 0.04% of Pekin Hardy Strauss's portfolio in Q2 2026, its #317 holding.
  • Pekin Hardy Strauss first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Pekin Hardy Strauss's Gilead Sciences position peaked at $1.48M in Q1 2020.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Pekin Hardy Strauss's 13F filing for Q2 2026, filed 30 Jul 2026.